Seizure Medication recalls

The FDA has published 103 recalls involving seizure medication since 2012. The latest was reported on 9 Sep 2026. Most were for potency & assay. Aidapak Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls103since 2012

Last 12 months7reported

Class I66% of total

Ongoing17latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 2Jan '25 0 0 4Apr 0 1 0Jul 0 0 1Oct 0 0 0Jan '26 0 0 0Apr 0 0 3Jul 2 1

Severity split

Class I 6 6%Class II 80 78%Class III 17 17%

Why seizure medication is recalled

Companies

Brands

By year

202666%
202588%
202433%
202377%
202277%
202188%
202099%
201988%
201833%
201788%

Ongoing seizure medication recalls

17 active

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS III	Trokendi XR, (topiramate) extended-release capsules, 50 mg recalled	Supernus Pharmaceuticals	Potency & Assay	Nationwide
26 Aug 2026Drug	CLASS II	Carbamazepine Tablets, USP, 200mg recalled	SUN Pharmaceutical Industries	Manufacturing (CGMP) Deviations	Nationwide
26 Aug 2026Drug	CLASS II	Carbamazepine Tablets, USP, 200mg recalledCarbamazepine	Golden State Medical Supply	Manufacturing (CGMP) Deviations	Nationwide
29 Jul 2026Drug	CLASS II	Divalproex Sodium Delayed-Release Tablets, USP, 500 mg recalledDivalproex Sodium	Bionpharma	Other	Nationwide
29 Jul 2026Drug	CLASS III	Trokendi XR, topiramate extended-release capsules, 25mg recalledTrokendi Xr	Supernus Pharmaceuticals	Potency & Assay	Nationwide
1 Jul 2026Drug	CLASS II	Lacosamide Tablets, USP, C V, 100mg recalled by Annora Pharma PrivateLacosamide	Annora Pharma Private	Packaging Defects	Nationwide

All seizure medication recalls, newest first

103 total

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS III	Trokendi XR, (topiramate) extended-release capsules, 50 mg recalled	Supernus Pharmaceuticals	Potency & Assay	Nationwide
26 Aug 2026Drug	CLASS II	Carbamazepine Tablets, USP, 200mg recalled	SUN Pharmaceutical Industries	Manufacturing (CGMP) Deviations	Nationwide
26 Aug 2026Drug	CLASS II	Carbamazepine Tablets, USP, 200mg recalledCarbamazepine	Golden State Medical Supply	Manufacturing (CGMP) Deviations	Nationwide
29 Jul 2026Drug	CLASS II	Divalproex Sodium Delayed-Release Tablets, USP, 500 mg recalledDivalproex Sodium	Bionpharma	Other	Nationwide
29 Jul 2026Drug	CLASS III	Trokendi XR, topiramate extended-release capsules, 25mg recalledTrokendi Xr	Supernus Pharmaceuticals	Potency & Assay	Nationwide
1 Jul 2026Drug	CLASS II	Lacosamide Tablets, USP, C V, 100mg recalled by Annora Pharma PrivateLacosamide	Annora Pharma Private	Packaging Defects	Nationwide
8 Oct 2025Drug	CLASS II	Carbamazepine Extended-Release Tablets recalledCarbamazepine	Amerisource Health Services	Potency & Assay	Nationwide
11 Jun 2025Drug	CLASS II	Lacosamide Oral Solution, USP, 10 mg/mL recalled by Apotex	Apotex	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS II	Lacosamide Tablets, 50mg recalled by Glenmark PharmaceuticalsLacosamide	Glenmark Pharmaceuticals Inc., U	Manufacturing (CGMP) Deviations	Nationwide
16 Apr 2025Drug	CLASS II	Lacosamide Tablets 200mg recalled by Glenmark PharmaceuticalsLacosamide	Glenmark Pharmaceuticals Inc., U	Manufacturing (CGMP) Deviations	Nationwide

Should you stop taking Seizure Medication?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.